Hideyasu Takagi

750 total citations
25 papers, 607 citations indexed

About

Hideyasu Takagi is a scholar working on Surgery, Hepatology and Molecular Biology. According to data from OpenAlex, Hideyasu Takagi has authored 25 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 7 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Hideyasu Takagi's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Hideyasu Takagi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Hideyasu Takagi collaborates with scholars based in Japan and United States. Hideyasu Takagi's co-authors include Shigeru Sasaki, Kohzoh Imai, Hiromu Suzuki, Masanori Nojima, Takashi Tokino, Yasuhisa Shinomura, Minoru Toyota, Reo Maruyama, Hiroyuki Yamamoto and Akimasa Nakao and has published in prestigious journals such as PLoS ONE, Carcinogenesis and Journal of Gastroenterology and Hepatology.

In The Last Decade

Hideyasu Takagi

24 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideyasu Takagi Japan 11 353 169 114 109 82 25 607
Katharina Balschun Germany 8 175 0.5× 260 1.5× 89 0.8× 70 0.6× 130 1.6× 8 619
Giampiero Macioce Italy 14 183 0.5× 87 0.5× 76 0.7× 66 0.6× 47 0.6× 21 751
Tomomitsu Doi Japan 15 271 0.8× 127 0.8× 94 0.8× 39 0.4× 38 0.5× 29 661
Hélène Mouly France 8 223 0.6× 164 1.0× 187 1.6× 64 0.6× 47 0.6× 14 475
Yibing Peng United States 14 153 0.4× 352 2.1× 71 0.6× 151 1.4× 39 0.5× 24 642
Masao Mitsunobu Japan 11 121 0.3× 185 1.1× 125 1.1× 198 1.8× 161 2.0× 21 594
Yasuhiko Kimura Japan 16 216 0.6× 127 0.8× 111 1.0× 149 1.4× 73 0.9× 28 532
Christa L. Whitney‐Miller United States 11 304 0.9× 222 1.3× 70 0.6× 301 2.8× 202 2.5× 29 679
Gioacchino D’Ambrosio Italy 11 313 0.9× 126 0.7× 103 0.9× 94 0.9× 187 2.3× 25 572
Gaosheng Huang China 13 152 0.4× 122 0.7× 55 0.5× 64 0.6× 68 0.8× 35 432

Countries citing papers authored by Hideyasu Takagi

Since Specialization
Citations

This map shows the geographic impact of Hideyasu Takagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyasu Takagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyasu Takagi more than expected).

Fields of papers citing papers by Hideyasu Takagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyasu Takagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyasu Takagi. The network helps show where Hideyasu Takagi may publish in the future.

Co-authorship network of co-authors of Hideyasu Takagi

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyasu Takagi. A scholar is included among the top collaborators of Hideyasu Takagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyasu Takagi. Hideyasu Takagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takagi, Hideyasu, et al.. (2020). Gastrointestinal: Abdominal aortic aneurysm caused symptoms mimicking superior mesenteric artery syndrome. Journal of Gastroenterology and Hepatology. 36(1). 43–43. 2 indexed citations
2.
Akutsu, Noriyuki, Yasushi Adachi, Hiroaki Mita, et al.. (2015). Mediastinal Yolk Sac Tumor Producing Protein Induced by Vitamin K Absence or Antagonist-II. Internal Medicine. 54(12). 1531–1536. 3 indexed citations
3.
Akutsu, Noriyuki, Shigeru Sasaki, Hideyasu Takagi, et al.. (2014). Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacy. International Journal of Clinical Oncology. 20(1). 105–110. 22 indexed citations
4.
Sasaki, Shigeru, Noriyuki Akutsu, Hideyasu Takagi, et al.. (2012). Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. Tumor Biology. 33(5). 1307–1317. 39 indexed citations
5.
Sasaki, Shigeru, Tadao Ishida, Minoru Toyota, et al.. (2011). Interferon-α/β and Anti-Fibroblast Growth Factor Receptor 1 Monoclonal Antibody Suppress Hepatic Cancer Cells In Vitro and In Vivo. PLoS ONE. 6(5). e19618–e19618. 10 indexed citations
6.
Akutsu, Noriyuki, Hirokazu Ohashi, Hideyasu Takagi, et al.. (2010). [Hyperplastic hepatic nodules in a case of idiopathic portal hypertension: changes in imaging findings during a 6-year follow-up].. PubMed. 107(1). 102–11. 1 indexed citations
7.
Kobayashi, Ko, Atsushi Takahashi, Kohei Hashimoto, et al.. (2009). [Liver metastasis with portal vein tumor thrombosis as a late recurrence of chromophobe renal cell carcinoma].. PubMed. 55(1). 23–5.
8.
Takagi, Hideyasu, Shigeru Sasaki, Hiromu Suzuki, et al.. (2008). Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. Journal of Gastroenterology. 43(5). 378–389. 100 indexed citations
9.
Akutsu, Noriyuki, Hideyasu Takagi, Hiroyuki Yamamoto, et al.. (2008). [Hemorrhage from varices of an interposed jejunum after choledochojejunostomy successfully treated by transileocolic vein obliteration].. PubMed. 105(11). 1648–55. 2 indexed citations
10.
Sato, Hironobu, Hiromu Suzuki, Minoru Toyota, et al.. (2007). Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis. 28(12). 2459–2466. 184 indexed citations
11.
Nakao, Akimasa, et al.. (1999). Clinical significance of alpha-fetoprotein mRNA during perioperative period in HCC.. PubMed. 46(25). 381–6. 24 indexed citations
12.
Nakao, Akimasa, et al.. (1997). False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis.. PubMed. 44(17). 1413–8. 64 indexed citations
13.
Narita, Tetsuharu, Chikako Mitsuoka, Noriyuki Kimura, et al.. (1997). Increased concentration of soluble E-selectin in the sera of breast cancer patients.. PubMed. 17(2B). 1367–72. 18 indexed citations
14.
Nishizawa, Koji, et al.. (1996). Estimation of the Exposure and a Risk-Benefit Analysis for a CT System Designed for a Lung Cancer Mass Screening Unit. Radiation Protection Dosimetry. 67(2). 101–108. 13 indexed citations
15.
Saitoh, Satoshi, Fujio Makita, Takeshi Matsumoto, et al.. (1996). [A resected case of cholangiocellular carcinoma associated with HCV antibody-positive liver cirrhosis].. PubMed. 93(2). 131–6. 1 indexed citations
16.
Maruyama, Hirotaka, Akihiro Harada, Tomohiro Kurokawa, et al.. (1994). Interleukin-6 as a marker of hepatic metabolism following hepatectomy.. PubMed. 41(3). 222–4. 3 indexed citations
17.
Torii, Akihito, et al.. (1994). Tumor localization as a prognostic factor in hepatocellular carcinoma.. PubMed. 41(1). 16–9. 3 indexed citations
18.
Nakao, Akimasa, et al.. (1994). Prognosis of cancer of the duodenal papilla of Vater in relation to clinicopathological tumor extension.. PubMed. 41(1). 73–8. 35 indexed citations
19.
Kojima, H., Yuko Kato, Kentaro Wada, et al.. (1989). [A case of coexistent adenocarcinoma and primary malignant lymphoma of the stomach].. PubMed. 35(3). 411–6. 2 indexed citations
20.
Ichikawa, Kunio, et al.. (1984). [Clinical and pathological studies on changes of interlobular bile ducts in acute viral hepatitis with zonal necrosis].. PubMed. 81(1). 66–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026